Take a look at some of the biggest movers in the premarket: Intel (INTC) – Intel…
Category: Finance
Financial Health, Fintech, Investment, Payments
Crypto firm Blockchain.com rides bitcoin mania to a $5.2 billion valuation
Blockchain co-founder and CEO Peter Smith speaks during the Web Summit tech conference in Lisbon, Portugal…
How 401(k) accounts killed pensions to become one of the most popular retirement plans for U.S. workers
About $33.1 trillion — that is how much Americans have saved up for retirement as of…
Stocks are set to rebound with Dow futures up 100 points, Intel shares gain
U.S. stocks are set to rebound on Wednesday as investors once again made bets on a…
GameStop shares fall 13% on lack of transformation detail, possible share sale
Investors finally got a look at GameStop‘s fundamentals following a Reddit-fueled trading frenzy earlier this year…
How 401(k) accounts killed pensions to become one of the most popular retirement plans for U.S. workers
About $33.1 trillion — that is how much Americans have saved up for retirement as of…
Samenvatting: numares kondigt FDA 510(k) indiening aan van AXINON System®, een NMR-platform voor op metabolomica gebaseerde, AI-gestuurde diagnostiek
BOSTON, & REGENSBURG, Duitsland–(BUSINESS WIRE)–Toonaangevend NMR-diagnostiekbedrijf numares AG heeft vandaag aangekondigd dat het bedrijf een aanvraag…
Resumen: numares anuncia la presentación ante la FDA de AXINON System®, una plataforma RMN para diagnósticos basados en la metabolómica e impulsados por IA
BOSTON y RATISBONA, Alemania–(BUSINESS WIRE)–numares AG, empresa líder en diagnósticos por resonancia magnética nuclear (RMN), ha…
numares announces FDA 510(k) Submission of AXINON System®, a NMR platform for metabolomics-based, AI-driven Diagnostics
BOSTON, & REGENSBURG, Germany–(BUSINESS WIRE)–Leading NMR diagnostics company numares AG today announced that the company made…
numares annuncia la richiesta di autorizzazione FDA 510(k) relativa alla piattaforma NMR AXINON System® per la diagnostica metabolomica basata sull’IA
BOSTON e RATISBONA, Germania–(BUSINESS WIRE)–Il leader della diagnostica tramite risonanza magnetica nucleare (NMR), numares AG, annuncia…
numares annonce la notification avant mise sur le marché FDA 510(k) du système AXINON®, une plateforme RMN dédiée au diagnostic utilisant l'IA et la métabolomique
BOSTON (États-Unis) et RASTISBONNE (Allemagne)–(BUSINESS WIRE)–La société de produits diagnostiques à RMN numares AG leader du…
Industry Ventures Raises Oversubscribed $850 Million Secondary Fund
SAN FRANCISCO–(BUSINESS WIRE)–Industry Ventures, a leading investment firm focused on venture capital, announced today the final…
Neighbor raises $53M for self-storage marketplace after 5x YoY revenue growth
Neighbor, which operates a self-storage marketplace, announced Wednesday that it has raised $53 million in a…
Nigerian fintech of the unbanked Bankly raises $2M led by Vault and Flutterwave
Nigeria remains a largely cash-dominated country. There are over 100 million adult Nigerians, of which more…
Stock futures are little changed amid renewed concern about pandemic recovery
On Tuesday, the major averages dipped on concerns about a global recovery from the pandemic.On Tuesday,…
Indonesian social commerce app KitaBeli gets $10M led by Go Ventures
Indonesian social commerce app KitaBeli’s team, including founders Prateek Chaturvedi (seated, left front row and Ivana…
Stock futures are little changed amid renewed concern about pandemic recovery
U.S. stock futures were flat in early morning trading Wednesday amid renewed investor concern about the…
Our favorite companies from Y Combinator’s W21 Demo Day: Part 2
We’ve reached the end of Y Combinator’s biggest Demo Day, which saw more than 300 companies…
Stock futures are flat amid renewed concern about pandemic recovery
U.S. stock futures were flat in overnight trading on Tuesday amid renewed investor concern about the…
One year after Covid-19 market bottom, Canaccord Genuity’s Tony Dwyer says stocks are in ‘no man’s land’
Canaccord Genuity’s Tony Dwyer is temporarily dialing back his appetite for stocks. On the one-year anniversary…